share_log

HC Wainwright & Co. Initiates Coverage On Anebulo Pharmaceuticals With Buy Rating, Announces Price Target of $6

HC Wainwright & Co. Initiates Coverage On Anebulo Pharmaceuticals With Buy Rating, Announces Price Target of $6

HC Wainwright & Co.以買入評級開始對Anebulo Pharmicals進行報道，宣佈目標股價爲6美元
Benzinga ·  2023/09/18 18:33

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy rating and announces Price Target of $6.

HC Wainwright&Co.分析師Raghuram Selvaraju以買入評級啟動對AneBulo製藥(納斯達克：ANEB)的報道，並宣佈目標價為6美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論